Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


IQuity Awarded Grant to Identify Alzheimer's Earlier


 
Chase Spurlock, PhD

Nashville-based data analytics company IQuity recently received a $320,000 grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The company - which utilizes data to predict, detect and monitor chronic disease - will build upon its diagnostic expertise to try to identify Alzheimer's at an earlier point in the disease's progression.

To date, IQuity has focused its research exclusively on autoimmune and related diseases, including multiple sclerosis, fibromyalgia syndrome and inflammatory bowel disease. The new grant will allow the company to expand its focus to include Alzheimer's disease and apply its genomic expertise to develop new diagnostic tools to help providers identify the disease early.

As part of its research activity for the award, IQuity will use its new machine learning-based data mining and analytics platform - which analyzes many types of information, including genomic datasets, claims data and electronic medical records - to predict and detect Alzheimer's. IQuity launched its analytics platform in July.

"This grant is a significant validation of the promise our genomics research and data analytics capabilities holds for people suffering from this debilitating disease," said IQuity CEO Chase Spurlock, PhD. "IQuity's advances in RNA testing and data science have great potential to create predictive diagnostic tools that will lead to an earlier diagnosis of Alzheimer's. New therapies that emerge for Alzheimer's will be most effective when administered early, which is difficult with today's diagnostic approach."

Alzheimer's is the sixth leading cause of death in the U.S., with 5.7 million people suffering from the disease. The Alzheimer's Association estimates the cost of healthcare and long-term care for individuals with Alzheimer's and dementias will total $277 billion in 2018.

"All of us at IQuity are excited and honored that the NIA and NIH support our approach to developing innovative technology that can facilitate early detection and treatment responses for people affected by Alzheimer's," said Spurlock. "We are proud to be part of a global community of researchers and data scientists who are committed to discovering new early detection methods, prevention plans, treatments and, hopefully, a cure for Alzheimer's."

Web:

IQuity

 
Share:

Related Articles:


Recent Articles

Benefits of Fetal Surgery for Spina Bifida Continue Through School Age

Read More

Vanderbilt-led Team Discovers New Genetic Disease and Defines Underlying Mechanism

Zebrafish, pediatric patients and DNA biobank-linked electronic health records inform research study

Read More

AMA Issues Checklist for the Transition to E/M Office Visit Changes

The American Medical Association (AMA) is helping physician practices integrate fundamental changes to the coding and documentation of evaluation and management (E/M) office visit services that account for nearly $23 billion in Medicare spending.

Read More

AHA's Maryjane Wurth To Retire In 2020; Michelle Hood To Join The Association

Maryjane Wurth, the American Hospital Association's (AHA) executive vice president and chief operating officer (COO), will retire next year after a long and distinguished career in the hospital association field.

Read More

Tennessee Sees Fewer Infant Deaths In 2018

Infant Mortality Data Dashboard Now Available

Read More

Amedisys Expanding Commitment to End-of-Life Care for Veterans

Third Largest Hospice Provider Cared for 5,540 Dying Veterans Last Year

Read More

AMA Applauds Relief from Documentation Burden in New Medicare Rule

Many physicians will have reduced documentation beginning in 2021

Read More

Oncology Innovation in Nashville

From personalized medicine to innovation in GI care, Middle Tennessee oncology leaders share promising news.

Read More

Critical Insights into Nashville Health

For the first time in nearly two decades, Nashville has a countywide assessment providing insights into the health and well-being of the community.

Read More

Physician Spotlight: Leading with Compassion

Hospice care is so much more than simply pain management. Compassus CMO Dr. Kurt Merkelz focuses on helping patients live fully until the end.

Read More

Email Print
 
 

 

 


Tags:
Alzheimer’s Disease, Chase Spurlock, IQuity, Predictive Diagnostics, RNA Testing, Senior Health
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: